The contribution of cellular FLIP long isoform protein (cFLIPL) to regulation of the type I IFN response in several primary cancers was reported by several groups with contradicting outcomes, so Gates and colleagues studied the underlying mechanism of action and concluded on an inhibitory function [169]. Here, CFLAR is linked to cancer.